Company intelligence / Profile preview

Racem Ephedrin

Uznach, Schwyz, Switzerlandstreuli-pharma.ch ↗

Ownership: Private
Development stage: Other

Overview

Streuli Pharma is a Swiss pharmaceutical company that specializes in the development, manufacturing, and distribution of a wide range of medicinal products. The company is well-known for its portfolio of established medications, including Racem-Ephedrin, which is used for the treatment of respiratory conditions and hypotension. Streuli Pharma operates as an independent family-owned business, focusing on high-quality production standards and serving the Swiss healthcare market. Their product range covers various therapeutic areas, including pain management, respiratory health, and emergency medicine.

Therapeutic areas: CardiovascularPulmonology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Racem Ephedrin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Racem Ephedrin.

Explore the full profile